Chemotherapy agents, such as doxorubicin, which is used to treat a variety of cancers including breast, esophageal, and endometrial carcinomas, work by increasing ROS production, activating the tumor suppressor p53, and ultimately leading to tumor cell death [81]. Here, TP53 is linked to neoplasm.